{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:08:36Z","timestamp":1759342116793},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ejim.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T11:07:29Z","timestamp":1119179249000},"page":"183-186","source":"Crossref","is-referenced-by-count":17,"title":["Silent versus cranial giant cell arteritis. Initial presentation and outcome of 50 biopsy-proven cases"],"prefix":"10.1016","volume":"16","author":[{"given":"Mohamed A.","family":"Hamidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Batard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Trewick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Agard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Ponge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Grolleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Barrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2005.02.001_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.1780310607","article-title":"Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950\u20131985","volume":"31","author":"Machado","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2005.02.001_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2005.02.001_bib4","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/art.1780241113","article-title":"Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin","volume":"24","author":"Calamia","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/00325481.1980.11715343","article-title":"The clinical pictures of giant cell arteritis: temporal arteritis, polymyalgia rheumatica and fever of unknown origin","volume":"67","author":"Malvalm","year":"1980","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2005.02.001_bib6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1532-5415.1993.tb07301.x","article-title":"Fever of unknown origin in elderly patients","volume":"41","author":"Knockaert","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2005.02.001_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2796.1990.tb00151.x","article-title":"Temporal arteritis: the silent presentation and delay in diagnosis","volume":"227","author":"Desmet","year":"1990","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2005.02.001_bib8","first-page":"1272","article-title":"Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short-term course","volume":"30","author":"Liozon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2005.02.001_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.20231","article-title":"Giant cell arteritis without clinically evident vascular involvement in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib12","first-page":"1484","article-title":"A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow up study of 164 patients","volume":"27","author":"Chevalet","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2005.02.001_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2005.02.001_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2005.02.001_bib16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000030185.67510.C0","article-title":"Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis","volume":"106","author":"Cid","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2005.02.001_bib17","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/01.CIR.0000066907.83923.32","article-title":"Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis. Angiogenic activity of interleukin-6 as a potential protective mechanism","volume":"107","author":"Hernandez-Rodriguez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","article-title":"A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant cell arteritis","volume":"47","author":"Hernandez-Rodriguez","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.md.0000119761.27564.c9","article-title":"M. Risk factors for cranial ischemic complications in giant cell arteritis","volume":"83","author":"Nesher","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2005.02.001_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/art.20523","article-title":"Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2005.02.001_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620505000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620505000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T08:50:01Z","timestamp":1548406201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620505000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0953620505000683"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2005.02.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}